Skip to content

Effect of Smoking, Abstention and Nicotine Replacement Therapy on Wound Healing

Effect of Smoking, Abstention and Nicotine Replacement Therapy on Wound Healing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00825851
Enrollment
78
Registered
2009-01-21
Start date
2000-08-31
Completion date
2001-01-31
Last updated
2009-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Healing

Brief summary

The aim was to determine the wound healing capacity in healthy never smokers and smokers who continue to smoke, or quit smoking using transdermal nicotine patch versus placebo patch.

Detailed description

Two wound healing models were applied: the excisional skin biopsy model to study wound histology and the suction blister model to study epidermal regeneration and skin transudate. In addition blood sampling was made to validate compliance to the study arms and to study systemic markers of collagen metabolism and oxidative stress. In addition, wound infections and wound ruptures were recorded post hoc as complications to the excisional skin biopsy model were not expected to occur.

Interventions

DRUGTransdermal nicotine patch

15mg/16h + 10mg/16h to be used 24h

DRUGPlacebo patch
BEHAVIORALSmoking cessation
BEHAVIORALContinuous smoking

subjects smoke 20 cigarettes per day

Sponsors

The Danish Medical Research Council
CollaboratorOTHER
Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* daily smokers smoking between 15-25 cigarettes per day and never smokers

Exclusion criteria

* chronic medical disease * atopic dermatitis or other skin disease * pregnancy * menopause * allergy to dressings or patches * current or recent medication with corticosteroids or NSAID

Design outcomes

Primary

MeasureTime frame
wound healing1, 4, 8, and 12 weeks

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026